Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Transplant Hepatology
How much do you factor in a patient's frailty in selection for transplant if the underlying driver for their debility is their underlying liver disease itself?
Related Questions
How do you determine which patients are good candidates to have their organ receive machine perfusion therapy before implantation?
How do you determine when you would treat an identified spleno-renal shunt and how?
What would be the right patient profile and experience for someone who may have (operational) tolerance and how do you approach immunosuppresison management (or withdrawal) in this patient?
For how long would you treat a patient with latent TB before allowing them to proceed with a liver transplant?
How does the identification of a hepatic adenoma in a male patient affect your management and evaluation?
In what scenario do you continue surveillance of benign liver tumors, e.g., hepatocellular adenoma, in pregnant patients?
When do you pursue liver biopsy for assessment of DILI?
How has the move away from a strict 6 month period of sobriety impacted your patient selection criteria for transplant of patients with alcohol associated liver disease?
What is your preferred approach to a patient with incidentally found low ceruloplasmin?
What are your biggest takeaways from the MASH-TAG 2025 conference?
